Volume Alert - CFN 58.25 Carefusion Corp $CFN Hit a high today of 58.28 Closing the day 10:30 at 58.25 +0.51 +0.88% With a day low of 57.68 and a total volume of 1,342,175.
CFN Recent Posts: http://investorshangout.com/Carefusion-Corp-CFN-50491/
CFN Carefusion Corp Recent Headline News
Becton Dickinson And CareFusion Announce Expiration Of HSR Act Waiting Period In Proposed Transaction
PR Newswire - Thu Nov 20, 8:05AM CST
Becton, Dickinson and Company (NYSE: BDX) ("BD"
and CareFusion Corporation (NYSE: CFN) ("CareFusion" today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act" , in connection with BD's proposed acquisition of CareFusion expired on November 19, 2014.
BDX: 130.10 (-0.01), CFN: 58.21 (+0.47)
Global Fetal and Neonatal Care Equipment Market 2015-2019: Key Vendors are CareFusion, Drager Medical, GE Healthcare and Phillips Healthcare
M2 - Thu Nov 20, 4:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkv8pr/global_fetal_and) has announced the addition of the "Global Fetal and Neonatal Care Equipment Market 2015-2019" report to their offering. One of the major trends emerging in this market is the increased popularity of fetal MRI, which provides multiplanar images that help in facilitating diagnosis of large or complex anomalies in the fetus. According to the report, one of the major factors driving the market is the increase in the number of preterm births across the world. Nearly 15 million preterm babies are born every year. Preterm infants face great risk from short and long-term complications and require warmth, breastfeeding support, and respiratory assistance. Further, the report states that one of the major challenges in the market is the increasing number of product recalls in the market. Product recalls hamper the adoption of the product and affect the brand image of the vendor. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Product Market Size and Forecast Market Size and Forecast Market Size and Forecast 09. Geographical Segmentation 10. Key Leading Countries 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - CareFusion - Dr?ger Medical - GE Healthcare - Phillips Healthcare - Analogic - Covidien - Fisher & Paykel Healthcare - Getinge - Ivy Biomedical Systems - Masimo - Natus Medical - Nonin Medical - OSI Systems - Smiths Medical - Spacelabs Healthcare - Utah Medical Products - Welch Allyn For more information visit http://www.researchandmarkets.com/research/wk..._fetal_and
BABY: 33.34 (+0.08), CFN: 58.21 (+0.47), OSIS: 68.60 (+0.65), UTMD: 58.00 (-0.30)
Uptrend Call Working As CareFusion Stock Rises 30.0% (CFN)
Comtex SmarTrend(R) - Wed Nov 19, 11:10AM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 3 months, CareFusion has returned 30.02% as of today's recent price of $57.73.
CFN: 58.21 (+0.47)
CareFusion Earnings In Retrospect: Up 0.2% in the Last 11 Days (CFN)
Comtex SmarTrend(R) - Mon Nov 17, 11:03AM CST
11 days ago, on November 6th, 2014, CareFusion (NYSE:CFN) reported its earnings. Analysts, on average, expected earnings of $0.49 per share on sales of $919.3 million. CareFusion actually reported earnings of $0.50 per share on sales of $922.0 million, beating EPS estimates by $0.01 and beating revenue estimates by $2.7 million. Since the company's report, shares of CareFusion have risen from $57.44 to $57.57, representing a gain of 0.2% in the past 11 days.
CFN: 58.21 (+0.47)
Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014
M2 - Thu Nov 13, 6:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/6jjwbm/asiapacific) has announced the addition of the "Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014" report to their offering. The market for patient monitoring includes multi-parameter vital sign monitors, wireless ambulatory telemetry monitors, electromyogram (EMG) devices and consumables, electroencephalogram (EEG) monitors, fetal and neonatal monitors and pulse oximetry monitors and sensors. Report Contents: - Identified Strategic Opportunities - Market Overview by Segment & Country - Trend Analysis by Segment & Country - Market Drivers & Limiters - Mergers & Acquisitions - Competitive Analysis Key Highlights: - Includes additional information on reimbursement changes - Brazil report includes a section in appendix on public vs. private market pricing - Descriptive and qualitative information for the market drivers and limiters for each segment - New large segment - Processed EEG Depth of Anesthesia Monitoring - Extensive Qualitative insights into emerging trends and consumer retail sub-markets Key Topics Covered: 1. Executive Summary 2. Research Methodology 3. Asia-Pacific Patient Monitoring Equipment Market Overview 4. Country Profiles 5. Multi-Parameter Vital Sign Monitoring Market 6. Wireless Ambulatory Telemetry Monitor Market 7. Electromyogram Monitoring And Diagnostic Market 8. Electroencephalogram Monitoring And Diagnostic Market 9. Fetal And Neonatal Monitoring Market 10. Pulse Oximeter Market 11. Abbreviations Companies Mentioned - ArjoHuntleigh - Beijing Choice - Bionet - Cardiac Science - CareFusion - Compumedics - Covidien - Draeger Medical - Edan - Fukuda Denshi - GE Healthcare - Grass Technologies - Masimo - Mediana - Mindray - Natus Medical - Nihon Kohden - Nonin - Omron Healthcare - Philips Healthcare - Smiths Medical - Spacelabs - Teijin Pharma - Welch Allyn For more information visit http://www.researchandmarkets.com/research/6j...siapacific
BABY: 33.34 (+0.08), CFN: 58.21 (+0.47)
CareFusion Shares Up 29.7% Since SmarTrend's Buy Recommendation (CFN)
Comtex SmarTrend(R) - Wed Nov 12, 9:50AM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 3 months, CareFusion has returned 29.71% as of today's recent price of $57.59.
CFN: 58.21 (+0.47)
CareFusion Q1 Earnings, Revenues Rise and Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:30AM CST
CareFusion Corporation (CFN) now expects adjusted earnings to increase in the range of $2.80-$2.95 per share, higher than the earlier band of $2.60-$2.75 per share.
BDX: 130.10 (-0.01), BCR: 166.54 (-0.13), BAX: 71.77 (-0.69), CFN: 58.21 (+0.47)
CareFusion beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:17PM CST
CFN: 58.21 (+0.47)
CareFusion Reports First Quarter Fiscal 2015 Results
PR Newswire - Thu Nov 06, 3:02PM CST
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended Sept. 30.
CFN: 58.21 (+0.47)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:35PM CST
BEBE: 2.54 (+0.02), ACET: 21.08 (+0.08), ANET: 75.40 (-1.60), FNGN: 32.29 (-0.08), CPST: 0.85 (+0.02), AUQ: 3.99 (+0.03), AMRN: 1.25 (unch), ED: 62.14 (-0.20), ENV: 52.01 (-0.57), FXCM: 15.96 (-0.18), BCEI: 36.92 (+1.12), GXP: 26.66 (+0.05), EAC: 11.00 (unch), DXCM: 50.99 (+0.51), CSC: 62.86 (+0.58), AEL: 26.99 (+0.10), HNSN: 0.80 (-0.03), CFN: 58.21 (+0.47), ANAC: 31.37 (+1.04), DAR: 18.98 (+0.08), GST: 4.06 (-0.01), ARC: 9.33 (-0.07), FIVN: 4.35 (-0.07), ELON: 1.84 (+0.01), FSLR: 49.48 (+0.66), EZPW: 10.79 (+0.11), ALIM: 5.47 (+0.02), FWM: 3.11 (+0.22), BRS: 70.37 (+0.87), ECOM: 17.73 (+0.40), FTEK: 4.10 (unch), CVT: 27.23 (+0.48), AL: 37.36 (-0.09), BBRG: 12.96 (+0.02), BPZ: 0.98 (+0.07), ECPG: 42.42 (-0.98), HTGC: 15.55 (-0.07), AIRM: 44.50 (+0.08), BNFT: 22.76 (+0.30), ENOC: 14.91 (+0.10), HPTX: 20.88 (+0.18), AGO: 24.98 (+0.28), FICO: 71.95 (+0.27), FF: 12.06 (-0.05), FI: 20.13 (+0.31), EVC: 5.59 (+0.12), EBS: 24.26 (+0.27), ABCO: 41.26 (-0.43), DIOD: 26.03 (+0.34), DIS: 88.98 (-0.84), EGOV: 17.85 (+0.45), APEI: 35.05 (-0.12), DVA: 75.05 (-0.07), CLVS: 50.12 (+1.84), HCI: 40.58 (+0.49), BRKR: 18.46 (+0.43), HGR: 20.40 (+0.39)
CareFusion Has Returned 29.7% Since SmarTrend Recommendation (CFN)
Comtex SmarTrend(R) - Wed Nov 05, 9:18AM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 3 months, CareFusion has returned 29.66% as of today's recent price of $57.57.
CFN: 58.21 (+0.47)
Will CVS Health (CVS) Keep its Earnings Streak Alive in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 2:30PM CST
CVS Health Corporation (CVS) is scheduled to report its third-quarter 2014 results before the opening bell on Nov 4.
AMSG: 50.56 (+0.68), CFN: 58.21 (+0.47), CVS: 89.40 (-0.19), HSIC: 131.14 (-0.96)
Clinical Trial Results, Product Approval Letter, Financial Results, and Upcoming Event - Research Reports on Receptos, Wright, United Therapeutics, Abbott and CareFusion
PR Newswire - Fri Oct 31, 7:40AM CDT
Today, Analysts Review released its research reports regarding Receptos Inc. (NASDAQ: RCPT), Wright Medical Group Inc. (NASDAQ: WMGI), United Therapeutics Corporation (NASDAQ: UTHR), Abbott Laboratories (NYSE: ABT) and CareFusion Corporation (NYSE: CFN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7594-100free.
ABT: 43.52 (+0.09), WMGI: 28.35 (-0.24), CFN: 58.21 (+0.47), UTHR: 129.48 (+1.48), RCPT: 115.99 (+8.04), WMGIZ: 4.35 (-0.01)
Morning Analysis on Health Care Equipment Stocks - Zimmer Holdings, Edwards Lifesciences, Varian Medical Systems, CareFusion, and Baxter Intl.
PR Newswire - Tue Oct 28, 7:35AM CDT
Investor-Edge has initiated coverage on the following equities: Zimmer Holdings Inc. (NYSE: ZMH), Edwards Lifesciences Corporation (NYSE: EW), Varian Medical Systems Inc. (NYSE: VAR), CareFusion Corporation (NYSE: CFN), and Baxter International Inc. (NYSE: BAX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, October 27, 2014, the NASDAQ Composite ended at 4,485.93, up 0.05%, the Dow Jones Industrial Average edged 0.07% higher to finish the day at 16,817.94, and the S&P 500 closed at 1,961.63, down 0.15%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 755.35, up 0.12%, with the index also advancing 5.54% in the previous three months. Register for your complimentary reports on these five stocks at:
ZMH: 110.29 (-0.26), VAR: 87.64 (-0.02), BAX: 71.77 (-0.69), CFN: 58.21 (+0.47), EW: 124.95 (-0.64)
Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 511.73 (-1.30), ELOS: 9.91 (+0.06), VRX: 142.13 (-0.34), ZLTQ: 28.59 (+0.47), VAR: 87.64 (-0.02), CFN: 58.21 (+0.47), STNR: 42.79 (+0.79)
SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of CareFusion Corporation -- CFN
GlobeNewswire - Wed Oct 22, 2:18PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the Delaware Court of Chancery on behalf of all common stockholders of CareFusion Corporation ("CareFusion" or the "Company" (NYSE:CFN) opposing the proposed acquisition of CareFusion by Becton, Dickinson and Company ("BD" .
CFN: 58.21 (+0.47)
Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion
PR Newswire - Tue Oct 21, 8:15AM CDT
Today, Analysts Review released its research reports regarding Simon Property Group Inc. (NYSE: SPG), The Regions Financial Corporation (NYSE: RF), American Capital Agency Corp. (NASDAQ: AGNC), CareFusion Corporation (NYSE: CFN) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7336-100free.
RF: 9.96 (-0.11), SPG: 178.34 (+1.97), CFN: 58.21 (+0.47), ALXN: 192.17 (+0.21), AGNC: 23.16 (+0.04)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of CareFusion Corporation of Class Action Against the Board of Directors of the Company Challenging the Fairness of the Sale of the Company to Becton Dickinson & Co. -- CFN
GlobeNewswire - Mon Oct 20, 9:28AM CDT
Levi & Korsinsky notifies investors of CareFusion Corporation ("CareFusion" or "the Company" (NYSE:CFN) of claims of breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Becton Dickinson & Co. ("Becton Dickinson" . A complaint was filed in Delaware state court.
BDX: 130.10 (-0.01), CFN: 58.21 (+0.47)
CFN Recent Posts: http://investorshangout.com/Carefusion-Corp-CFN-50491/
CFN Carefusion Corp Recent Headline News
Becton Dickinson And CareFusion Announce Expiration Of HSR Act Waiting Period In Proposed Transaction
PR Newswire - Thu Nov 20, 8:05AM CST
Becton, Dickinson and Company (NYSE: BDX) ("BD"
and CareFusion Corporation (NYSE: CFN) ("CareFusion" today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act" , in connection with BD's proposed acquisition of CareFusion expired on November 19, 2014. BDX: 130.10 (-0.01), CFN: 58.21 (+0.47)
Global Fetal and Neonatal Care Equipment Market 2015-2019: Key Vendors are CareFusion, Drager Medical, GE Healthcare and Phillips Healthcare
M2 - Thu Nov 20, 4:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkv8pr/global_fetal_and) has announced the addition of the "Global Fetal and Neonatal Care Equipment Market 2015-2019" report to their offering. One of the major trends emerging in this market is the increased popularity of fetal MRI, which provides multiplanar images that help in facilitating diagnosis of large or complex anomalies in the fetus. According to the report, one of the major factors driving the market is the increase in the number of preterm births across the world. Nearly 15 million preterm babies are born every year. Preterm infants face great risk from short and long-term complications and require warmth, breastfeeding support, and respiratory assistance. Further, the report states that one of the major challenges in the market is the increasing number of product recalls in the market. Product recalls hamper the adoption of the product and affect the brand image of the vendor. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Product Market Size and Forecast Market Size and Forecast Market Size and Forecast 09. Geographical Segmentation 10. Key Leading Countries 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - CareFusion - Dr?ger Medical - GE Healthcare - Phillips Healthcare - Analogic - Covidien - Fisher & Paykel Healthcare - Getinge - Ivy Biomedical Systems - Masimo - Natus Medical - Nonin Medical - OSI Systems - Smiths Medical - Spacelabs Healthcare - Utah Medical Products - Welch Allyn For more information visit http://www.researchandmarkets.com/research/wk..._fetal_and
BABY: 33.34 (+0.08), CFN: 58.21 (+0.47), OSIS: 68.60 (+0.65), UTMD: 58.00 (-0.30)
Uptrend Call Working As CareFusion Stock Rises 30.0% (CFN)
Comtex SmarTrend(R) - Wed Nov 19, 11:10AM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 3 months, CareFusion has returned 30.02% as of today's recent price of $57.73.
CFN: 58.21 (+0.47)
CareFusion Earnings In Retrospect: Up 0.2% in the Last 11 Days (CFN)
Comtex SmarTrend(R) - Mon Nov 17, 11:03AM CST
11 days ago, on November 6th, 2014, CareFusion (NYSE:CFN) reported its earnings. Analysts, on average, expected earnings of $0.49 per share on sales of $919.3 million. CareFusion actually reported earnings of $0.50 per share on sales of $922.0 million, beating EPS estimates by $0.01 and beating revenue estimates by $2.7 million. Since the company's report, shares of CareFusion have risen from $57.44 to $57.57, representing a gain of 0.2% in the past 11 days.
CFN: 58.21 (+0.47)
Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014
M2 - Thu Nov 13, 6:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/6jjwbm/asiapacific) has announced the addition of the "Asia-Pacific Markets for Patient Monitoring Devices and Equipment 2014" report to their offering. The market for patient monitoring includes multi-parameter vital sign monitors, wireless ambulatory telemetry monitors, electromyogram (EMG) devices and consumables, electroencephalogram (EEG) monitors, fetal and neonatal monitors and pulse oximetry monitors and sensors. Report Contents: - Identified Strategic Opportunities - Market Overview by Segment & Country - Trend Analysis by Segment & Country - Market Drivers & Limiters - Mergers & Acquisitions - Competitive Analysis Key Highlights: - Includes additional information on reimbursement changes - Brazil report includes a section in appendix on public vs. private market pricing - Descriptive and qualitative information for the market drivers and limiters for each segment - New large segment - Processed EEG Depth of Anesthesia Monitoring - Extensive Qualitative insights into emerging trends and consumer retail sub-markets Key Topics Covered: 1. Executive Summary 2. Research Methodology 3. Asia-Pacific Patient Monitoring Equipment Market Overview 4. Country Profiles 5. Multi-Parameter Vital Sign Monitoring Market 6. Wireless Ambulatory Telemetry Monitor Market 7. Electromyogram Monitoring And Diagnostic Market 8. Electroencephalogram Monitoring And Diagnostic Market 9. Fetal And Neonatal Monitoring Market 10. Pulse Oximeter Market 11. Abbreviations Companies Mentioned - ArjoHuntleigh - Beijing Choice - Bionet - Cardiac Science - CareFusion - Compumedics - Covidien - Draeger Medical - Edan - Fukuda Denshi - GE Healthcare - Grass Technologies - Masimo - Mediana - Mindray - Natus Medical - Nihon Kohden - Nonin - Omron Healthcare - Philips Healthcare - Smiths Medical - Spacelabs - Teijin Pharma - Welch Allyn For more information visit http://www.researchandmarkets.com/research/6j...siapacific
BABY: 33.34 (+0.08), CFN: 58.21 (+0.47)
CareFusion Shares Up 29.7% Since SmarTrend's Buy Recommendation (CFN)
Comtex SmarTrend(R) - Wed Nov 12, 9:50AM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 3 months, CareFusion has returned 29.71% as of today's recent price of $57.59.
CFN: 58.21 (+0.47)
CareFusion Q1 Earnings, Revenues Rise and Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:30AM CST
CareFusion Corporation (CFN) now expects adjusted earnings to increase in the range of $2.80-$2.95 per share, higher than the earlier band of $2.60-$2.75 per share.
BDX: 130.10 (-0.01), BCR: 166.54 (-0.13), BAX: 71.77 (-0.69), CFN: 58.21 (+0.47)
CareFusion beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:17PM CST
CFN: 58.21 (+0.47)
CareFusion Reports First Quarter Fiscal 2015 Results
PR Newswire - Thu Nov 06, 3:02PM CST
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended Sept. 30.
CFN: 58.21 (+0.47)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:35PM CST
BEBE: 2.54 (+0.02), ACET: 21.08 (+0.08), ANET: 75.40 (-1.60), FNGN: 32.29 (-0.08), CPST: 0.85 (+0.02), AUQ: 3.99 (+0.03), AMRN: 1.25 (unch), ED: 62.14 (-0.20), ENV: 52.01 (-0.57), FXCM: 15.96 (-0.18), BCEI: 36.92 (+1.12), GXP: 26.66 (+0.05), EAC: 11.00 (unch), DXCM: 50.99 (+0.51), CSC: 62.86 (+0.58), AEL: 26.99 (+0.10), HNSN: 0.80 (-0.03), CFN: 58.21 (+0.47), ANAC: 31.37 (+1.04), DAR: 18.98 (+0.08), GST: 4.06 (-0.01), ARC: 9.33 (-0.07), FIVN: 4.35 (-0.07), ELON: 1.84 (+0.01), FSLR: 49.48 (+0.66), EZPW: 10.79 (+0.11), ALIM: 5.47 (+0.02), FWM: 3.11 (+0.22), BRS: 70.37 (+0.87), ECOM: 17.73 (+0.40), FTEK: 4.10 (unch), CVT: 27.23 (+0.48), AL: 37.36 (-0.09), BBRG: 12.96 (+0.02), BPZ: 0.98 (+0.07), ECPG: 42.42 (-0.98), HTGC: 15.55 (-0.07), AIRM: 44.50 (+0.08), BNFT: 22.76 (+0.30), ENOC: 14.91 (+0.10), HPTX: 20.88 (+0.18), AGO: 24.98 (+0.28), FICO: 71.95 (+0.27), FF: 12.06 (-0.05), FI: 20.13 (+0.31), EVC: 5.59 (+0.12), EBS: 24.26 (+0.27), ABCO: 41.26 (-0.43), DIOD: 26.03 (+0.34), DIS: 88.98 (-0.84), EGOV: 17.85 (+0.45), APEI: 35.05 (-0.12), DVA: 75.05 (-0.07), CLVS: 50.12 (+1.84), HCI: 40.58 (+0.49), BRKR: 18.46 (+0.43), HGR: 20.40 (+0.39)
CareFusion Has Returned 29.7% Since SmarTrend Recommendation (CFN)
Comtex SmarTrend(R) - Wed Nov 05, 9:18AM CST
SmarTrend identified an Uptrend for CareFusion (NYSE:CFN) on August 18th, 2014 at $44.40. In approximately 3 months, CareFusion has returned 29.66% as of today's recent price of $57.57.
CFN: 58.21 (+0.47)
Will CVS Health (CVS) Keep its Earnings Streak Alive in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 2:30PM CST
CVS Health Corporation (CVS) is scheduled to report its third-quarter 2014 results before the opening bell on Nov 4.
AMSG: 50.56 (+0.68), CFN: 58.21 (+0.47), CVS: 89.40 (-0.19), HSIC: 131.14 (-0.96)
Clinical Trial Results, Product Approval Letter, Financial Results, and Upcoming Event - Research Reports on Receptos, Wright, United Therapeutics, Abbott and CareFusion
PR Newswire - Fri Oct 31, 7:40AM CDT
Today, Analysts Review released its research reports regarding Receptos Inc. (NASDAQ: RCPT), Wright Medical Group Inc. (NASDAQ: WMGI), United Therapeutics Corporation (NASDAQ: UTHR), Abbott Laboratories (NYSE: ABT) and CareFusion Corporation (NYSE: CFN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7594-100free.
ABT: 43.52 (+0.09), WMGI: 28.35 (-0.24), CFN: 58.21 (+0.47), UTHR: 129.48 (+1.48), RCPT: 115.99 (+8.04), WMGIZ: 4.35 (-0.01)
Morning Analysis on Health Care Equipment Stocks - Zimmer Holdings, Edwards Lifesciences, Varian Medical Systems, CareFusion, and Baxter Intl.
PR Newswire - Tue Oct 28, 7:35AM CDT
Investor-Edge has initiated coverage on the following equities: Zimmer Holdings Inc. (NYSE: ZMH), Edwards Lifesciences Corporation (NYSE: EW), Varian Medical Systems Inc. (NYSE: VAR), CareFusion Corporation (NYSE: CFN), and Baxter International Inc. (NYSE: BAX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, October 27, 2014, the NASDAQ Composite ended at 4,485.93, up 0.05%, the Dow Jones Industrial Average edged 0.07% higher to finish the day at 16,817.94, and the S&P 500 closed at 1,961.63, down 0.15%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 755.35, up 0.12%, with the index also advancing 5.54% in the previous three months. Register for your complimentary reports on these five stocks at:
ZMH: 110.29 (-0.26), VAR: 87.64 (-0.02), BAX: 71.77 (-0.69), CFN: 58.21 (+0.47), EW: 124.95 (-0.64)
Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 511.73 (-1.30), ELOS: 9.91 (+0.06), VRX: 142.13 (-0.34), ZLTQ: 28.59 (+0.47), VAR: 87.64 (-0.02), CFN: 58.21 (+0.47), STNR: 42.79 (+0.79)
SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of CareFusion Corporation -- CFN
GlobeNewswire - Wed Oct 22, 2:18PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the Delaware Court of Chancery on behalf of all common stockholders of CareFusion Corporation ("CareFusion" or the "Company"
(NYSE:CFN) opposing the proposed acquisition of CareFusion by Becton, Dickinson and Company ("BD" . CFN: 58.21 (+0.47)
Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion
PR Newswire - Tue Oct 21, 8:15AM CDT
Today, Analysts Review released its research reports regarding Simon Property Group Inc. (NYSE: SPG), The Regions Financial Corporation (NYSE: RF), American Capital Agency Corp. (NASDAQ: AGNC), CareFusion Corporation (NYSE: CFN) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7336-100free.
RF: 9.96 (-0.11), SPG: 178.34 (+1.97), CFN: 58.21 (+0.47), ALXN: 192.17 (+0.21), AGNC: 23.16 (+0.04)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of CareFusion Corporation of Class Action Against the Board of Directors of the Company Challenging the Fairness of the Sale of the Company to Becton Dickinson & Co. -- CFN
GlobeNewswire - Mon Oct 20, 9:28AM CDT
Levi & Korsinsky notifies investors of CareFusion Corporation ("CareFusion" or "the Company"
(NYSE:CFN) of claims of breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Becton Dickinson & Co. ("Becton Dickinson" . A complaint was filed in Delaware state court. BDX: 130.10 (-0.01), CFN: 58.21 (+0.47)
